

Cesca designs, manufactures and sells advanced devices created specifically for the regenerative medicine bioprocessing market. Among its major competitors, Cesca Therapeutics is ranked in 11th place for NPS while Zimmer Biomet is 1st, and Biogen is 2nd.Their current market cap is $12.42M